Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Angelastro

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Oncotarget|February 11, 2016
Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptideCharles C Cates, Angelo D Arias, Lynn S Nakayama Wong, et al.
Oncogenesis|May 17, 2020
PRMT1 promotes neuroblastoma cell survival through ATF5Zhong-Yan Hua, Jeanne N Hansen, Miao He, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Oncotarget|February 11, 2016
Regression/eradication of gliomas in mice by a systemically-deliverable ATF5 dominant-negative peptideCharles C Cates, Angelo D Arias, Lynn S Nakayama Wong, et al.
Oncogenesis|May 17, 2020
PRMT1 promotes neuroblastoma cell survival through ATF5Zhong-Yan Hua, Jeanne N Hansen, Miao He, et al.
Pageof 4